Clinical Trial to Evaluate Ultrasonic Surgical Device in Chronic Pressure Ulcer
Clinical Trial to Evaluate Efficacy and Safety of Ultrasonic Surgical Device (ULSC-12D)in Chronic Pressure Ulcer
2 other identifiers
interventional
30
1 country
3
Brief Summary
Study objective The purpose of this trial is to evaluate the efficacy and safety of the investigational device, ULSD-12D, as Compared to the comparator, SONOCA-180, in chronic wound.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2013
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 31, 2013
CompletedFirst Posted
Study publicly available on registry
December 11, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedApril 7, 2014
April 1, 2014
6 months
October 31, 2013
April 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The number of microorganisms on wound bed
Investigator measured the number of microorganisms on wound bed at pre and post debridement using nitrocellulose filter.
Baseline and 30minuts post debridement
Secondary Outcomes (1)
necrotic tissue region
Baseline and 30minuts post debridement
Study Arms (2)
ULSD-12D
EXPERIMENTALultrasound surgical device made by Ultech.
SONOCA-180
ACTIVE COMPARATORultrasound surgical device made by Soering
Interventions
Eligibility Criteria
You may qualify if:
- over 20 years of age
- subject who has untreated wounds
- subject who has wound size over 3cm x 3cm
- subject who has wound over stage 2
You may not qualify if:
- cellulitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Samsung Medical Center
Seoul, Gangnam-gu, 135-710, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Hanyang University Hospital
Seoul, Seongdong-gu, 133-791, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chanyeong - Heo, Ph.D
Seoul National University Bundang Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
October 31, 2013
First Posted
December 11, 2013
Study Start
August 1, 2013
Primary Completion
February 1, 2014
Study Completion
March 1, 2014
Last Updated
April 7, 2014
Record last verified: 2014-04